JP2009513692A5 - - Google Patents

Download PDF

Info

Publication number
JP2009513692A5
JP2009513692A5 JP2008538400A JP2008538400A JP2009513692A5 JP 2009513692 A5 JP2009513692 A5 JP 2009513692A5 JP 2008538400 A JP2008538400 A JP 2008538400A JP 2008538400 A JP2008538400 A JP 2008538400A JP 2009513692 A5 JP2009513692 A5 JP 2009513692A5
Authority
JP
Japan
Prior art keywords
provisos
lipoxygenase
inhibition
diseases
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008538400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009513692A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2006/004042 external-priority patent/WO2007052000A1/en
Publication of JP2009513692A publication Critical patent/JP2009513692A/ja
Publication of JP2009513692A5 publication Critical patent/JP2009513692A5/ja
Withdrawn legal-status Critical Current

Links

JP2008538400A 2005-11-01 2006-10-30 炎症の治療に有用なピラゾール化合物 Withdrawn JP2009513692A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73192805P 2005-11-01 2005-11-01
PCT/GB2006/004042 WO2007052000A1 (en) 2005-11-01 2006-10-30 Pyrazoles useful in the treatment of inflammation

Publications (2)

Publication Number Publication Date
JP2009513692A JP2009513692A (ja) 2009-04-02
JP2009513692A5 true JP2009513692A5 (https=) 2009-12-17

Family

ID=36572265

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008538400A Withdrawn JP2009513692A (ja) 2005-11-01 2006-10-30 炎症の治療に有用なピラゾール化合物

Country Status (4)

Country Link
US (1) US20090088463A1 (https=)
EP (1) EP1943225A1 (https=)
JP (1) JP2009513692A (https=)
WO (1) WO2007052000A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006032851A1 (en) * 2004-09-20 2006-03-30 Biolipox Ab Pyrazole compounds useful in the treatment of inflammation
TW200800911A (en) * 2005-10-20 2008-01-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
EP1943234A1 (en) * 2005-10-31 2008-07-16 Biolipox AB Triazole compounds as lipoxygenase inhibitors
TW200732320A (en) * 2005-10-31 2007-09-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
FR2639636B1 (fr) * 1988-11-30 1994-03-04 Novapharme Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
US5464860A (en) * 1988-11-30 1995-11-07 Novapharme N(pyrazol-3-yl) benzamides and pharmaceutical compositions
US5258397A (en) * 1988-11-30 1993-11-02 Novapharme 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
JPH07508039A (ja) * 1992-05-20 1995-09-07 メルク　エンド　カンパニー　インコーポレーテッド ４−アザステロイドのエステル誘導体
US5536727A (en) * 1992-05-20 1996-07-16 Merck & Co., Inc. 17-Ethers and thioethers of 4-aza-steroids
US5665737B1 (en) * 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
US6372770B1 (en) * 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
US5663357A (en) * 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
AU778393B2 (en) * 1999-05-12 2004-12-02 Ortho-Mcneil Pharmaceutical, Inc. Pyrazole carboxamides useful for the treatment of obesity and other disorders
US6632815B2 (en) * 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
GB0002666D0 (en) * 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
WO2001058869A2 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
GB0011094D0 (en) * 2000-05-08 2000-06-28 Black James Foundation Gastrin and cholecystokinin receptor ligands (III)
KR20030030029A (ko) * 2000-09-22 2003-04-16 니혼노야쿠가부시키가이샤 Ｎ-(4-피라졸릴)아미드 유도체 및 농원예용 약제 그리고그 사용방법
JP4465133B2 (ja) * 2001-02-08 2010-05-19 クミアイ化学工業株式会社 イソオキサゾリン誘導体及びこれを有効成分とする除草剤
DE10110750A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
WO2003037274A2 (en) * 2001-11-01 2003-05-08 Icagen, Inc. Pyrazole-amides and-sulfonamides
TWI263497B (en) * 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
WO2004039795A2 (en) * 2002-10-29 2004-05-13 Fujisawa Pharmaceutical Co., Ltd. Amide compounds for the treatment of hyperlipidemia
AU2003286876A1 (en) * 2002-11-01 2004-06-07 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of jak and other protein kinases
EP1571671A4 (en) * 2002-12-13 2008-04-02 Matsushita Electric Industrial Co Ltd OPTICAL DATA DISTRIBUTION EQUIPMENT
US7429581B2 (en) * 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
WO2004080999A1 (en) * 2003-03-14 2004-09-23 Biolipox Ab Pyrazole compounds useful in the treatment of inflammation
SE0300705D0 (sv) * 2003-03-14 2003-03-14 Biolipox Ab New compounds
MXPA05011503A (es) * 2003-04-25 2006-05-31 Johnson & Johnson Inhibidores de la c-fms cinasa.
GB0312609D0 (en) * 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
WO2006032852A1 (en) * 2004-09-20 2006-03-30 Biolipox Ab Pyrazole compounds useful uin the treatment of inflammation
TW200800911A (en) * 2005-10-20 2008-01-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
TW200732320A (en) * 2005-10-31 2007-09-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
EP1943234A1 (en) * 2005-10-31 2008-07-16 Biolipox AB Triazole compounds as lipoxygenase inhibitors

Similar Documents

Publication Publication Date Title
IL194949A0 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
NO20084502L (no) Tetrahydropyrrolopyrimidinedioner og deres anvendelse som humane neutrofil elastase inhibitorer
HUE039731T2 (hu) l,3-difenilprop-2-én-l-on-származékok alkalmazása májbetegségek kezelésére
ECSP088902A (es) Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios
WO2009127822A3 (en) Bis-aryl compounds for use as medicaments
EP2034839A4 (en) TREATMENT OF NEURODEEGENERATIVE DISEASES BY INHIBITION OF HSP90
CN102036649A8 (zh) 精氨酸盐及其治疗口腔疾病的用途
DE602007005120D1 (de) 2-pyridonderivate zur behandlung von krankheiten oder leiden, bei denen eine inhibierung der aktivität der neutrophilen elastase von nutzen ist
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
MX2010001020A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
JP2007520565A5 (https=)
PT2056804E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares
IL200091A0 (en) Use of chitosans for the treatment of nail inflammatory diseases
JP2008513426A5 (https=)
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
JO2999B1 (ar) مركب ثلاثي حلقي و استخدامه الدوائي
FR2943537B1 (fr) Traitement des nevrites vestibulaires par l'acetyl-l-leucine
WO2007009720A3 (en) Prodrugs of pyrazoline compounds, their preparation and use as medicaments
NO20085028L (no) Substituerte karboksamider
PT1828151E (pt) Derivados de malonamida como inibidores de gama-secretase para o tratamento da doença de alzheimer
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
JP2008513427A5 (https=)
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
WO2006108681A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria